United for Medical Research publishes tribute to Francis Collins

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

United for Medical Research released a video tribute honoring NIH Director Francis Collins, who plans to step down this year. 

Collins will continue his research at the National Human Genome Research Institute after this transition. Lawrence Tabak will serve as NIH interim director. 

Members of the biomedical research community described Collins as a “trusted voice” who has been able to “make NIH a bipartisan priority” with “great charm and elegance,” UMR officials said.

Collins, a physician-geneticist, is the longest-serving presidentially appointed NIH director, having served three U.S. presidents over more than 12 years. Under his leadership, the NIH has undertaken health issues including Alzheimer’s disease, cancer, opioid use disorder, rare diseases, and the COVID-19 pandemic—and the NIH budget has grown from $30 billion

in 2009 to $41.3 billion in 2021.

Collins is known for his commitment to developing and retaining young researchers and working to make biomedical research more accessible and equitable, recently encouraging an end to “manels”—all-male speaking panels. 

Leaders from the following organizations participated in the video: Alzheimer’s Association, American Association for the Advancement of Science, Association of American Universities, Association of Public and Land-grant Universities, Corning Life Sciences, Harvard University, Johns Hopkins University, Northwestern University, Stanford University, Thermo Fisher Scientific, Vanderbilt University, Vanderbilt University Medical Center, and Washington University in St. Louis.  

A transcript of their full statements is available here.

YOU MAY BE INTERESTED IN

Roger Lo, professor of medicine, dermatology, and molecular and medical pharmacology and investigator at the UCLA Health Jonsson Comprehensive Cancer Center, was awarded a $2 million grant from NIH to investigate innovative strategies to prevent drug resistance in melanoma treatment and improve the effectiveness of MAPK inhibitors, a common treatment for patients with melanomas that carry the BRAFV600 mutation.
West African genetic ancestry was associated with increased prostate cancer among men living in disadvantaged neighborhoods but not among men living in more affluent neighborhoods, according to a new study led by NIH researchers. The findings suggest that neighborhood environment may play a role in determining how genetic ancestry influences prostate cancer risk. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login